Teladoc Health Inc (NYSE:TDOC) SVP Andrew Turitz sold 8,202 shares of Teladoc Health stock in a transaction on Monday, December 3rd. The stock was sold at an average price of $64.14, for a total transaction of $526,076.28. Following the transaction, the senior vice president now directly owns 9,378 shares of the company’s stock, valued at $601,504.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

TDOC stock traded down $1.59 during midday trading on Friday, reaching $54.22. The company had a trading volume of 22,998 shares, compared to its average volume of 1,340,719. The company has a market cap of $4.19 billion, a PE ratio of -32.72 and a beta of 0.92. Teladoc Health Inc has a 1-year low of $30.88 and a 1-year high of $89.05. The company has a quick ratio of 8.99, a current ratio of 8.99 and a debt-to-equity ratio of 0.40.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Thursday, November 1st. The health services provider reported ($0.34) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.36) by $0.02. The business had revenue of $111.00 million during the quarter, compared to the consensus estimate of $109.94 million. Teladoc Health had a negative return on equity of 14.05% and a negative net margin of 31.32%. Teladoc Health’s revenue for the quarter was up 61.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.55) earnings per share. On average, analysts anticipate that Teladoc Health Inc will post -1.47 EPS for the current fiscal year.

A number of equities analysts have commented on TDOC shares. SunTrust Banks lifted their price objective on shares of Teladoc Health to $77.00 and gave the stock a “buy” rating in a research report on Thursday, August 9th. Jefferies Financial Group set a $90.00 price objective on shares of Teladoc Health and gave the stock a “buy” rating in a research report on Friday, September 28th. Citigroup reaffirmed a “buy” rating and set a $95.00 price objective on shares of Teladoc Health in a research report on Friday, September 28th. Canaccord Genuity boosted their target price on shares of Teladoc Health from $86.00 to $94.00 and gave the company a “buy” rating in a research report on Friday, September 28th. Finally, Craig Hallum boosted their target price on shares of Teladoc Health from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, October 15th. Four equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $85.06.

A number of hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in Teladoc Health by 26.9% in the third quarter. Vanguard Group Inc. now owns 5,874,182 shares of the health services provider’s stock valued at $507,236,000 after purchasing an additional 1,244,388 shares in the last quarter. BlackRock Inc. raised its stake in Teladoc Health by 9.0% during the second quarter. BlackRock Inc. now owns 5,318,850 shares of the health services provider’s stock worth $308,759,000 after acquiring an additional 437,136 shares in the last quarter. Bank of America Corp DE raised its stake in Teladoc Health by 82.8% during the second quarter. Bank of America Corp DE now owns 1,883,185 shares of the health services provider’s stock worth $109,318,000 after acquiring an additional 853,076 shares in the last quarter. Zevenbergen Capital Investments LLC raised its stake in Teladoc Health by 3.9% during the second quarter. Zevenbergen Capital Investments LLC now owns 1,629,170 shares of the health services provider’s stock worth $94,574,000 after acquiring an additional 61,325 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC raised its stake in Teladoc Health by 1.6% during the third quarter. Gilder Gagnon Howe & Co. LLC now owns 1,501,216 shares of the health services provider’s stock worth $129,630,000 after acquiring an additional 23,940 shares in the last quarter.

WARNING: This report was reported by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.watchlistnews.com/teladoc-health-inc-tdoc-svp-andrew-turitz-sells-8202-shares-of-stock/2667640.html.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

See Also: NASDAQ Stock Market Explained

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.